Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalOperating Expenses
Others
Ratios

Inogen (INGN) EBITDA (2016 - 2022)

Inogen has reported EBITDA over the past 10 years, most recently at -$9.9 million for Q3 2022.

  • Quarterly results put EBITDA at -$9.9 million for Q3 2022, down 179.03% from a year ago — trailing twelve months through Sep 2022 was -$25.1 million (down 321.36% YoY), and the annual figure for FY2021 was -$5.3 million, down 1.37%.
  • EBITDA for Q3 2022 was -$9.9 million at Inogen, down from -$4.7 million in the prior quarter.
  • Over the last five years, EBITDA for INGN hit a ceiling of $16.1 million in Q3 2018 and a floor of -$23.1 million in Q4 2021.
  • Median EBITDA over the past 5 years was $5.4 million (2019), compared with a mean of $2.8 million.
  • Biggest five-year swings in EBITDA: surged 1974.49% in 2018 and later tumbled 356.34% in 2021.
  • Inogen's EBITDA stood at $10.1 million in 2018, then tumbled by 116.95% to -$1.7 million in 2019, then crashed by 196.19% to -$5.1 million in 2020, then crashed by 356.34% to -$23.1 million in 2021, then surged by 57.08% to -$9.9 million in 2022.
  • The last three reported values for EBITDA were -$9.9 million (Q3 2022), -$4.7 million (Q2 2022), and -$23.1 million (Q4 2021) per Business Quant data.